bluuebunny/crossref_metadata_2025_split huggingface dataset:
Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial
Authors: Thibaudin Marion , Roussot Nicolas , Burlot Chloé , Schmitt Antonin , Vincent Julie , Tharin Zoé , Bengrine Leila , Bellio Hélène , Bertaut Aurélie , Hampe Léa , Daumoine Susy , Rederstorff Emilie , Peroz Morgane , Huppe Titouan , Derangère Valentin , Rageot David , Simard John , Truntzer Caroline , Fumet Jean David , Ghiringhelli Francois 
Published: January 2025

Abstract
In the tumour microenvironment, IL-1α promotes neoangiogenesis, matrix remodelling, tumour proliferation, chemoresistance, and metastases. Highly expressed in human colorectal cancers, IL-1α is associated with poor prognosis. XB2001, a fully human monoclonal antibody neutralizing IL-1α, was evaluated for safety and preliminary efficacy with trifluridine/tipiracil (FTD/TPI) and bevacizumab in metastatic colorectal cancer patients previously treated with oxaliplatin- and irinotecan-based chemotherapies. This single institution, phase 1 study used a 3 + 3 design to assess XB2001 at doses of 250 mg, 500 mg and 1000 mg every 14 days, associated with FTD/TPI 35 mg/m² (days 1–5 and 8-12, every 28 days) (NCT05201352). The Maximum Tolerated Dose of XB2001 + FTD/TPI was then associated in combination with bevacizumab (5 mg/kg, days 1 and 15). Safety, efficacy, pharmacokinetics and pharmacodynamics were assessed. Seventeen patients (median age: 67.4 years) were enroled. No patient exhibited dose-limiting toxicity at any dose. The most common treatment-related adverse events (TRAE) of any grade (G) were diarrhoea (35.3%), nausea (47.1%) and anaemia (35.3%). G3-4 TRAE were neutropenia (17.6%) hypertension and infection (5.9% each). The RP2D (recommended phase 2 dose) of XB2001 was 1000 mg. The disease control rate was 76%, with 23% of patients achieving an objective response, including one complete response. Response and longer progression-free survival were associated with a decrease in serum IL-6 levels during therapy. High intratumoral IL-1α expression at baseline and CD8/PD-L1 infiltration are associated with a better progression-free survival. The combination of XB2001 with FTD/TPI and bevacizumab is feasible and safe, and showed encouraging clinical activity in chemotherapy-resistant mCRC.
Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study
Authors: Wang Haiyu , Cui Guangying , Cheng Ming , Aji Tuerganaili , Li Guotao , Hu Xinjun , Li Guangming , Zhang Shixi , Zhang Yanyang , Diao Linqi , Li Pan , Wang Ling , Yuan Yiqiang , Qian Guowu , Zhang Ruiqing , Jin Xiaoli , Wang Juan , Luo Hong , Zhang Donghua , Wang Mingming , Li Silin , Song Zhan , Yang Mengzhao , Su Guanyue , Sun Ranran , Chang Junbiao , Yu Zujiang , Ren Zhigang 
Published: January 2025

Abstract
Azvudine and nirmatrelvir-ritonavir (Paxlovid) were widely used to treat patients with COVID-19 in China during the Omicron wave. However, the efficacy and safety of azvudine versus Paxlovid are poorly established. This study included 40,876 hospitalized patients with COVID-19 from eleven hospitals in Henan and Xinjiang Provinces, China. Clinical outcomes were compared between the two drugs via Kaplan–Meier analysis and Cox regression models. Additionally, in vitro and in vivo experiments were used to evaluate the antitumor effects and safety of both drugs. Single-cell RNA sequencing was performed to elucidate the tumor immune landscape after azvudine treatment. After propensity score matching, 2404 azvudine and 1202 Paxlovid recipients from Henan Province were included. Cox regression revealed that azvudine was related to an 18% lower risk of all-cause death than Paxlovid (95% CI: 0.676–0.987), was not obviously different in composite disease progression. The robustness of the findings was verified by the Xinjiang cohort and three sensitivity analyses. Fewer adverse events were observed in the azvudine group. Subgroup analysis revealed that azvudine provided greater benefits for patients with malignant tumors, significantly reducing both all-cause death (hazard ratio [HR]: 0.33, 95% CI: 0.20−0.54) and composite disease progression (HR: 0.54, 95% CI: 0.33−0.88). Furthermore, azvudine can suppress the growth of hepatocellular carcinoma (HCC) by regulating CD4+ T and CD8+ T cells in vivo. These findings suggest that azvudine therapy is not inferior to Paxlovid in hospitalized COVID-19 patients and has fewer adverse effects. Notably, azvudine may offer greater clinical benefit for patients with HCC.
Targeting EGFR-binding protein SLC7A11 enhancing antitumor immunity of T cells via inducing MHC-I antigen presentation in nasopharyngeal carcinoma
Authors: Wang Haihua , Fan Songqing , Zhan Yuting , Xu Yue , Du Yao , Luo Jiadi , Zang Hongjing , Peng Shuping , Wang Weiyuan 
Published: January 2025

Abstract
Approximately 80% of nasopharyngeal carcinoma (NPC) patients exhibit EGFR overexpression. The overexpression of EGFR has been linked to its potential role in modulating major histocompatibility complex class I (MHC-I) molecules. We discovered that EGFR, operating in a kinase-independent manner, played a role in stabilizing the expression of SLC7A11, which subsequently inhibited MHC-I antigen presentation. This mechanism, in turn, provided protection to NPC cells against T cell-mediated cytotoxicity. The underlying molecular processes revealed that the high and stable expression of SLC7A11 hindered the nuclear entry of GR, thereby suppressing TAP1 transcription and the presentation of MHC-I molecules. Additionally, elevated SLC7A11 expression led to an increase in FAF2 expression and triggered ERAD-dependent degradation of MHC-I, resulting in a reduction of MHC-I molecules on the cell membrane. The NPC patients exhibiting high EGFR and low MHC-I expression, combined with a scarcity of CD8+ T cells (EGFRhighMHC-IlowCD8few phenotype), experienced considerably shorter overall survival times compared to other situations. What is more, our study demonstrated that sorafenib had the capability to enhance the MHC-I antigen presentation process, thereby facilitating T cell-mediated killing of NPC cells via targeting SLC7A11. Consequently, targeting SLC7A11 with sorafenib emerges as a promising therapeutic strategy for the treatment of NPC.
Hypoxia-triggered ERRα acetylation enhanced its oncogenic role and promoted progression of renal cell carcinoma by coordinating autophagosome-lysosome fusion
Authors: Feng Chun , Kong Demin , Tong Binghua , Liang Yonghui , Xu Fuyi , Yang Yangyang , Wu Yingying , Chi Xiaodong , Wei Pengfei , Yang Yang , Zhang Guilong , Tian Geng , Xu Zhaowei 
Published: January 2025

Abstract
Estrogen-related receptor α (ERRα) is dysregulated in many types of cancer and exhibits oncogenic activity by promoting tumorigenesis and metastasis of cancer cells. However, its defined role in renal cell carcinoma (RCC) has not been fully elucidated. To reveal the biological function of ERRα and determine the underlying regulatory mechanism in RCC, the quantitative proteomics analysis and mechanism investigation were conducted. The results demonstrated that ERRα promoted the proliferation and tumorigenesis of RCC cells by maintaining lysosome-dependent autophagy flux. ERRα inhibition impaired the transcriptional expression of LAMP2 and VAMP8 and blocked the fusion of autophagosomes with lysosomes, causing the impairment of the autophagy-lysosome pathway and tumor repression in RCC. Moreover, VHL mutant-induced hyperactive hypoxia signaling in RCC triggered p300/CBP-mediated acetylation at the DNA-binding domain of ERRα, and this acetylation promoted its affinity toward targeting DNA and Parkin-mediated ubiquitination and proteasome-dependent degradation. This regulatory model enhanced ERRα transactivation on the expression of LAMP2 and VAMP8, which then maintained autophagy flux and RCC progression. Pharmaceutical inhibition on ERRα acetylation-mediated autophagy-lysosome pathway led to growth repression and sunitinib sensitivity of RCC cells. Taken together, this study uncovered a novel regulatory mechanism of acetylation contributing to the transcriptional performance and the oncogenic role of ERRα in RCC progression by modulating the autophagy-lysosome pathway. These findings might provide a novel approach for the clinical diagnosis and resolution of sunitinib resistance of RCC.
A compliant metastructure design with reconfigurability up to six degrees of freedom
Authors: Yang Humphrey , Patel Dinesh K. , Johnson Tate , Zhong Ke , Olson Gina , Majidi Carmel , Islam Mohammad F. , Zhang Teng , Yao Lining 
Published: January 2025

Abstract
Compliant mechanisms with reconfigurable degrees of freedom are gaining attention in the development of kinesthetic haptic devices, robotic systems, and mechanical metamaterials. However, available devices exhibit limited programmability and form-customizability, restricting their versatility. To address this gap, we propose a metastructure concept featuring reconfigurable motional freedom and tunable stiffness, adaptable to various form factors and applications. These devices incorporate passive flexures and actively stiffness-changing rods to modify kinematic freedom. A rational design pipeline informs the flexures’ topological arrangements, geometric parameters, and control signals based on targeted mobilities, enabling the creation of unitary joints with up to six degrees of freedom. Our demonstrative application examples include a wrist device that has an effective stiffness of 0.370 Nm/deg (unlocked state, 5% displacement) to 2.278 Nm/deg (locked state, 1% displacement) to enable dynamic joint mobility control, a haptic thimble device (2.27-52.815 Nmm−1 at 1% displacement) that mimics the sensation of touching physical materials ranging from soft gel to metal surfaces, and a wearable device composed of multiple joints tailored for the arm and hand to augment haptic experiences or facilitate muscle training. We believe the presented method can help democratize compliant metastructures development and expand their versatility for broader contexts.
Ultra-high electrostriction and ferroelectricity in poly (vinylidene fluoride) by ‘printing of charge’ throughout the film
Authors: Zhang Ningyi , Dong Xiaobing , He Shihui , Liang Zhao , Li Weipeng , Qian Qihao , Jiang Chao 
Published: January 2025

Abstract
Electrostriction is an important electro-mechanical property in poly (vinylidene fluoride) (PVDF) films, which describes the proportional relation between the electro-stimulated deformation and the square of the electric field. Generally, traditional methods to improve the electrostriction of PVDF either sacrifice other crystalline-related key properties or only influence minimal regions around the surface. Here, we design a unique electret structure to fully exploit the benefits of internal crystal in PVDF films. Through the 3D printing of charged ink, we have obtained the best electrostrictive and ferroelectric properties among PVDF-based materials so far. The optimized electrostrictive coefficient M
33 (324 × 10−18 m2 V−2) is 104 times that of normal PVDF films, and the piezoelectric constant d
33 (298 pm V−1) is close to 10 times its traditional limit. The proposed 3D electret structure and the bottom-up approach to ‘print the charge’ open up a new way to design and adapt the electroactive polymers in smart devices and systems.
Time series data on typhoid fever incidence during outbreaks from 2000 to 2022
Authors: Koh Dae-Hyup , Duong Monica , Kipshidze Nodar , Pitzer Virginia E. , Kim Jong-Hoon 
Published: January 2025

Abstract
This article presents a comprehensive dataset compiling reported cases of typhoid fever from culture-confirmed outbreaks across various geographical locations from 2000 through 2022, categorized into daily, weekly, and monthly time series. The dataset was curated by identifying peer-reviewed epidemiological studies available in PubMed, OVID-Medline, and OVID-Embase. Time-series incidence data were extracted from plots using WebPlotDigitizer, followed by verification of a subset of the dataset. The primary aim of this dataset is to serve as a foundational tool for researchers and policymakers, enabling the development of robust, model-based strategies for the control of typhoid fever outbreaks. The article describes the method by which the dataset has been compiled and how the quality of the data has been verified. Furthermore, it discusses the dataset’s potential applications in optimizing vaccination campaigns, improving public health planning, and tailoring interventions to specific epidemiologic contexts. This article contributes significantly to the field of infectious disease modeling, offering a valuable resource for enhancing typhoid fever control measures globally.
Self-referential belief shares common neural correlates with general belief
Authors: Bruns Emily , Scholz Immanuel , Koppe Georgia , Kirsch Peter , Gerchen Martin Fungisai 
Published: January 2025

Abstract
Belief processing and self-referential processing have been consistently associated with cortical midline structures, and cortical regions such as the vmPFC have been implicated in general belief processing. The neural correlates of self-referential belief are yet to be investigated. In this fMRI study, we presented 120 statements with trait adjectives to N = 27 healthy participants, who subsequently judged whether they believed these trait adjectives applied to themselves, a close person, or a public person. Thereafter, participants rated their certainty in this judgment. Expectedly, self-referential processing evoked a large cluster in the vmPFC, ACC, and dmPFC. For belief, we found a cluster in the vmPFC, ACC, and amPFC during statement presentation, partially overlapping with that for self-referential processing. The cluster for self-belief vs. disbelief was similar in location and size to that for general belief processing. For uncertainty, we found dmPFC activation. We replicated vmPFC involvement in belief processing and found a common neural correlate for belief and self-belief in the vmPFC. Furthermore, we replicated the role of the dmPFC in uncertainty, supporting a dual neural process model of belief and certainty.
Highly efficient and rapid removal of Congo red dye from textile wastewater using facile synthesized Mg/Ni/Al layered double hydroxide
Authors: Mohamed Eslam A. , Ahmed Hend M. , Altalhi Amal A. , Al-Shamiri Hamdan A. S. , Negm Nabel A. 
Published: January 2025

Abstract
Layered double hydroxides (LDH) are compounds with unique structures of hydroxide functional groups on their surfaces, and they have the proper arrangement of divalent and trivalent cations to adjust their unique catalytic actions. LDH was synthesized utilizing the co-precipitation technique and was thermally treated at 300 °C. The prepared compounds were chemically and structurally elucidated using FT-IR, XRD, SEM, BET, TG-DTA, and XPS characterization. We found that the thermal treatment of the prepared magnesium/nickel-LDH resulted in dehydration and dehydroxylation in its chemical structure. The crystallinity, the surface area, and the pore volume of the formed meso- and micropores were improved considerably after the thermal treatment. The efficiency of the uptake process was increased from 84 to 97% after the thermal treatment process, and the adsorption process tracked the Freundlich adsorption isotherm and pseudo-second-order kinetic model. The kinetics indicated the occurrence of three stages, and the diffusion of dye molecules into the pores was the rate-determining step. Different real water sample treatments showed the applicability of the thermally treated Mg/Ni/Al-LDH in the treatment process under optimized conditions. The presented mechanism of the uptake process using the prepared compounds comprises several interactions between the dye molecules and the thermally treated Mg/Ni/Al-LDH. The study presented the new application for Mg/Ni/Al-LDH in the as-prepared and thermally treated forms to uptake Congo-red (CR) dye from textile effluents.
Synthesis and evaluation of amino acid ionic liquid for enhanced oil recovery: experimental and modeling simulation studies
Authors: Mansour E. M. , Hosny R. , Mohamed Ammona S. , Abdelhafiz Fatma M. 
Published: January 2025

Abstract
Recovering the remaining oil after primary and secondary extraction methods poses a significant challenge. Enhanced oil recovery (EOR) techniques, which involve injecting fluids into reservoirs, aim to increase recovery rates. Ionic liquids, known for their adaptability, are emerging as promising agents in EOR, improving oil displacement by reshaping fluid properties and interacting with reservoir rocks. This study investigates the eco-friendly amino acid ionic liquid, AAIL [G0.5 C12][Pro], for EOR applications, focusing on its characterization and performance. Using pre-prepared quaternary ammonium salt PAMAM G0.5 C12 and proline, AAIL [G0.5 C12][Pro] was synthesized and confirmed via FTIR and 1H-NMR analyses. Rheological analysis identified 7 g of AAIL [G0.5 C12][Pro] as the optimal concentration for peak performance. Laboratory sand-pack displacement experiments demonstrated an 11% increase in oil recovery at this concentration. Further, a 3D reservoir model simulation validated the enhanced oil recovery potential of AAIL [G0.5 C12][Pro]. The study introduces the novel amino acid ionic liquid [G0.5 C12][Pro], which demonstrates superior effectiveness in enhancing oil recovery through significant wettability modification and interfacial tension reduction, underscoring its potential as an effective and environmentally friendly EOR agent compared to other ionic liquids and conventional methods.
Enhancing single-cell transcriptomics using interposed anchor oligonucleotide sequences
Authors: Sun Jianfeng , Philpott Martin , Loi Danson , Hoffman Gabriela , Robson Jonathan , Mehta Neelam , Calcutt Eleanor , Gamble Vicki , Brown Tom , Brown Tom , Oppermann Udo , Cribbs Adam P. 
Published: January 2025

Abstract
Single-cell transcriptomics, which utilises barcodes and unique molecular identifiers (UMIs) for polyA+ mRNA capture, is compromised by oligonucleotide synthesis errors. To address this, we modified the oligonucleotide capture design and integrated an interposed anchor between the barcode and the UMI. This design significantly reduces the need to discard reads due to synthesis inaccuracies. Our results demonstrate that this anchor-enhanced design substantially improves gene expression profiles in droplet-based single-cell sequencing analyses.
A transdisciplinary, comparative analysis reveals key risks from Arctic permafrost thaw
Authors: Gartler Susanna , Scheer Johanna , Meyer Alexandra , Abass Khaled , Bartsch Annett , Doloisio Natalia , Falardeau Jade , Hugelius Gustaf , Irrgang Anna , Haukur Ingimundarson Jón , Jungsberg Leneisja , Lantuit Hugues , Nymand Larsen Joan , Lodi Rachele , Martin Victoria Sophie , Mercer Louise , Nielsen David , Overduin Paul , Povoroznyuk Olga , Rautio Arja , Schweitzer Peter , Speetjens Niek Jesse , Tomaškovičová Soňa , Timlin Ulla , Vanderlinden Jean-Paul , Vonk Jorien , Westerveld Levi , Ingeman-Nielsen Thomas 
Published: January 2025

Abstract
Permafrost thaw poses diverse risks to Arctic environments and livelihoods. Understanding the effects of permafrost thaw is vital for informed policymaking and adaptation efforts. Here, we present the consolidated findings of a risk analysis spanning four study regions: Longyearbyen (Svalbard, Norway), the Avannaata municipality (Greenland), the Beaufort Sea region and the Mackenzie River Delta (Canada) and the Bulunskiy District of the Sakha Republic (Russia). Local stakeholders’ and scientists’ perceptions shaped our understanding of the risks as dynamic, socionatural phenomena involving physical processes, key hazards, and societal consequences. Through an inter- and transdisciplinary risk analysis based on multidirectional knowledge exchanges and thematic network analysis, we identified five key hazards of permafrost thaw. These include infrastructure failure, disruption of mobility and supplies, decreased water quality, challenges for food security, and exposure to diseases and contaminants. The study’s novelty resides in the comparative approach spanning different disciplines, environmental and societal contexts, and the transdisciplinary synthesis considering various risk perceptions.
Monolithic, hybrid and particulate lignin-based hydrogels for sustainable CO2 capture
Authors: Moreno Adrian , Delgado-Lijarcio Javier , Ronda Juan C. , Galià Marina , Lligadas Gerard 
Published: January 2025

Lignin-based particulate hydrogels using lignin nanoparticles (LNPs) as cross-linking agents exhibit efficient CO2 absorption and enhanced mechanical properties, highlighting their potential applications in different areas.
New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic
Authors: Sehnal Borek , Hruda Martin , Matej Radoslav , Robova Helena , Drozenova Jana , Pichlik Tomas , Halaska Michael J. , Rob Lukas , Dundr Pavel 
Published: January 2025

AbstractThe International Federation of Gynaecology and Obstetrics (FIGO) introduced a new staging system for endometrial carcinoma FIGO 2023 in June 2023. The new staging system differs significantly from previous versions by incorporating other non-anatomical parameters (histological type of tumour, tumour grade and the presence of massive lymphovascular space involvement as well as the molecular classification of the tumour). The FIGO 2023 staging system enhances the accuracy of prognostic assessments for patients at a specific stage with better options for targeted treatment. Another objective was to synchronise staging as much as possible with the European oncogynaecological ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma established in 2021. However, several changes are controversial. Routine molecular classification of endometrial carcinomas is not yet commonly available in most countries of the world. Another limitation of the FIGO 2023
staging system of endometrial cancer is the inclusion of variables whose definitions are still evolving, as well as variables that are subject to considerable interobserver variability in their assessment. Advantages, controversies, and limitations for clinical practice of the new FIGO 2023 endometrial cancer staging system are discussed.